PATENT CLAIM ANALYSIS

Application Number: 15960909
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "183000"]

Abstract:
The use of 1-phenyl-3-dimethylaminopropane compounds for the treatment of rheumatoid pain, especially rheumatoid arthritic pain, very especially preferably chronic rheumatoid arthritic pain.

Claim (Index 11):
A method as claimed in  claim 9 , wherein R 3  denotes H, and the compound of Formula I is present in the form of a mixture of diastereomers wherein the diastereomer having the relative configuration Ia is present in a higher proportion than the other diastereomer.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 91.0
- Lexical Diversity: 1.47059
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11294449', '12850208', '10448454', '11003534', '11133190']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7610150351128625
- 35 USC 102 Novelty (BERT): 0.5270673845672426
- Combined Prediction Score: 0.7376202700583006
- Mean Citation Score: 281.06451
- Max Citation Score: 312.57202
- Similarity Product: 222.7911156855237

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test